Pacific Biosciences of California, Inc.
PACB
$2.44
$0.124.96%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.61% | -38.26% | -38.94% | 24.14% | -38.64% |
| Total Receivables | 4.20% | -0.54% | 4.36% | -24.83% | -3.62% |
| Inventory | -19.14% | -21.51% | -19.80% | 3.67% | -3.69% |
| Prepaid Expenses | -33.36% | -27.71% | -9.76% | -13.26% | 11.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -56.52% | -12.28% | 130.00% | 1,693.33% | 130.00% |
| Total Current Assets | -32.52% | -34.19% | -34.28% | -33.20% | -33.78% |
|
|
|||||
| Total Current Assets | -32.52% | -34.19% | -34.28% | -33.20% | -33.78% |
| Net Property, Plant & Equipment | 31.27% | 16.24% | 1.82% | -32.49% | -34.23% |
| Long-term Investments | -13.90% | -13.90% | -31.26% | -31.26% | -20.43% |
| Goodwill | -13.90% | -13.90% | -31.26% | -31.26% | -20.43% |
| Total Other Intangibles | -96.30% | -96.13% | -95.96% | -14.75% | -5.50% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -6.59% | -9.98% | -14.51% | -12.88% | -28.46% |
| Total Assets | -44.61% | -45.31% | -48.45% | -27.81% | -23.62% |
|
|
|||||
| Total Accounts Payable | 35.63% | -13.91% | -33.18% | 10.14% | -25.10% |
| Total Accrued Expenses | 36.43% | -7.14% | 6.76% | -51.93% | -44.65% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -66.08% | -70.35% | -45.42% | -0.55% | 7.78% |
| Total Finance Division Other Current Liabilities | -5.65% | -22.40% | 18.17% | -27.72% | -85.34% |
| Total Other Current Liabilities | -5.65% | -22.40% | 18.17% | -27.72% | -85.34% |
| Total Current Liabilities | 5.35% | -23.77% | -8.70% | -30.23% | -67.39% |
|
|
|||||
| Total Current Liabilities | 5.35% | -23.77% | -8.70% | -30.23% | -67.39% |
| Long-Term Debt | -27.77% | -27.60% | -27.60% | -27.43% | 0.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 220.68% | 165.45% | 73.78% | -52.81% | -50.34% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -83.62% | -77.99% | -77.79% | -2.65% | 11.60% |
| Total Liabilities | -23.06% | -24.86% | -24.66% | -27.84% | -12.13% |
|
|
|||||
| Common Stock & APIC | 3.37% | 3.65% | 3.88% | 4.52% | 3.18% |
| Retained Earnings | -23.41% | -25.18% | -34.31% | -16.85% | -22.44% |
| Treasury Stock & Other | -73.28% | 151.05% | 224.51% | 92.69% | 184.40% |
| Total Common Equity | -92.04% | -87.52% | -85.88% | -27.76% | -40.67% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -92.04% | -87.52% | -85.88% | -27.76% | -40.67% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -92.04% | -87.52% | -85.88% | -27.76% | -40.67% |
|
|
|||||